Q VYJUVEK revenue and $623.2 million since U.S. launch VYJUVEK launched in Germany in 3Q; launched in France and Japan in ...
Something unusual is happening to biotech stocks: They’re going up. A drug-pricing deal between Pfizer and the White House and a spate of deals have sent the SPDR S&P Biotech exchange-traded fund up 9 ...
Shares of Sana Biotechnology (NASDAQ:SANA) climbed ~24% in the morning hours on Wednesday, triggering several trading halts after Canadian hedge fund manager Eric Jackson said that he is long the ...
In September 2024, Akeso, a little-known Chinese biopharmaceutical company, announced that clinical trials had shown that its new drug could halt the progression of a type of lung cancer for nearly a ...
Oct 14 (Reuters) - U.S. biotech firm Nabla Bio said on Tuesday it has signed a second major research partnership with Japanese drugmaker Takeda Pharmaceutical (4502.T), opens new tab, deepening their ...
After years on the sidelines while investors piled into the next big thing in AI or crypto, biotech is back in focus. The question is whether this rally marks a real recovery or just another ...
Evommune, which is developing drugs targeting the sources of chronic inflammatory diseases, filed for an initial public offering. The Palo Alto, Calif., company is seeking a New York Stock Exchange ...
Federal funding cuts and threats to higher education are putting key ingredients of Boston’s recipe for biotech success in jeopardy For more than a decade, Boston has been the undisputed capital of ...
VanEck Biotech ETF focuses on major biotech firms, offering lower volatility than smaller peers. This is a passive ETF, capturing the MVIS US Listed Biotech 25 Index without picking stocks actively.
Mary Brunkow speaks at an event Tuesday at Seattle’s Institute for Systems Biology celebrating her 2025 Nobel Prize in Physiology or Medicine. (ISB Photo / Alex Garland) The groundbreaking immunology ...
Benzinga’s Edge Stock Rankings system scores stocks across key measures including momentum, growth, value and quality. The momentum score serves as a key indicator for traders looking to capitalize on ...
In this article, we will look at the top 14 Biotech Stocks with High Potential. On October 1, Evan Seigerman, head of healthcare research at BMO Capital Markets, appeared on CNBC’s “The Exchange” to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results